World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33038864

Number of visits today: 3330

Number of downloads: 16231146

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Hasan AH, Hussen NH, Shakya S, Jamalis J, Pratama MRF, Chander S, Kharkwal H, Murugesan S. In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions. Struct Chem. [DOI: 10.1007/s11224-022-01996-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

For:

Hasan AH, Hussen NH, Shakya S, Jamalis J, Pratama MRF, Chander S, Kharkwal H, Murugesan S. In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions. Struct Chem. [DOI: 10.1007/s11224-022-01996-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]

Number	Citing Articles
1	Hasan AH, Shakya S, Hussain FHS, Murugesan S, Chander S, Pratama MRF, Jamil S, Das B, Biswas S, Jamalis J. Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids. J Biomol Struct Dyn 2023;:1-13. [PMID: 36591704 DOI: 10.1080/07391102.2022.2162583] [Reference Citation Analysis]
2	Hamaamin Hussen N, Hameed Hasan A, Jamalis J, Shakya S, Chander S, Kharkwal H, Murugesan S, Ajit Bastikar V, Pyarelal Gupta P. Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies. Computational Toxicology 2022;24:100247. [DOI: 10.1016/j.comtox.2022.100247] [Reference Citation Analysis]
3	Salih RHH, Hasan AH, Hussein AJ, Samad MK, Shakya S, Jamalis J, Hawaiz FE, Pratama MRF. One-pot synthesis, molecular docking, ADMET, and DFT studies of novel pyrazolines as promising SARS-CoV-2 main protease inhibitors. Res Chem Intermed. [DOI: 10.1007/s11164-022-04831-5] [Reference Citation Analysis]